While corporations, including tech giants like Microsoft, are betting big on this technology, there are a few potential problems with BECCS, as my colleague James Temple laid out in a new story.... Read more »
With a bachelor’s degree from Princeton and a doctorate in physics from the University of Wisconsin, Jakubowski had spent most of his life in school. While his peers kick-started their shiny new... Read more »
MIT Technology Review Narrated: Inside the strange limbo facing millions of IVF embryos Millions of embryos created through IVF sit frozen in time, stored in tanks around the world. The number is... Read more »
Much of the momentum is being driven by two related forces: the rise of AI agents and the rapid democratization of AI tools. AI agents, whether designed for automation or assistance, are... Read more »
PainChek was cleared by Australia’s Therapeutic Goods Administration in 2017, and national rollout funding from Canberra helped embed it in hundreds of nursing homes in the country. The system has also won... Read more »
Similar trends have appeared in cold climes. Researchers often measure cold tolerance by a person’s “brown adipose,” a type of fat that is specialized for generating heat (unlike white fat, which primarily... Read more »
BECCS is also substantially less expensive for buyers than, say, direct air capture, with weighted average prices of $210 a ton compared with $490 among the deals to date, according to CDR.fyi.... Read more »
1 California’s AI safety bill has been signed into law It holds AI companies legally accountable if their chatbots fail to protect users. (TechCrunch)+ It also requires chatbots to remind young users that... Read more »
Breaking up Big Tech through antitrust laws would hinder innovation, says Clegg, arguing that the idea “completely ignores the benefits users gain from large network effects.” Users stick with these outsize channels... Read more »
The need for personalization extends to sales and marketing operations too as pharma companies are increasingly needing to compete for the attention of health-care professionals (HCPs). Estimates suggest that biopharmas were able... Read more »